Aims

Highly cross-linked polyethylene (HXLPE) has greatly improved the durability of total hip arthroplasty (THA) in young patients because of its improved wear characteristics. Few studies have followed this population into the second decade, and therefore the purpose of this investigation was to evaluate the clinical outcome for THA patients 50 years of age and younger at a minimum of 15 years postoperatively. The second purpose was to evaluate the radiological findings secondary to wear or mechanical failure of the implant.

Young patients are at increased risk of revision after primary THA (THA). The bearing surface may be of importance for the longevity of the joint. We aimed to compare the risk of revision of primary stemmed cementless THA with MoM and CoC with metal-on-highly-crosslinked-polyethylene (MoXLP) bearings in patients between 20–54 years. From NARA, we included 2,153 MoM, 4,120 CoC and 10,329 MoXLP THA operated between 1995 and 2017. Kaplan-Meier estimator was used for calculation of THA survivorship and Cox regression to estimate the hazard ratio (HR) of revision (95% CI) due to any and specific causes. MoXLP was reference. The median follow-up was 10.3 years for MoM, 6.6 years for CoC and 4.8 years for MoXLP. 15 years postoperatively the Kaplan-Meier survival estimates were 80% (78–83%) for MoM, 92% (91–93%) for CoC and 94% (93–95%) for MoXLP. The 0–2, 2–7 and 7–15 years adjusted HRs of revision by any cause were 1.4 (0.9–2.4), 3.2 (2.1–5.1) and 3.9 (1.9–7.9) for MoM and 1.1 (0.8–1.4), 1.0 (0.7–1.3) and 2.5 (1.3–4.8) for CoC bearings. After 7–15 years follow-up, the unadjusted HR of revision due to aseptic loosening was 5.4 (1.2–24) for MoM and 4.2 (0.9–20) for CoC THA. MoM and CoC had a 7–15 year adjusted HR of revision due to ‘other’ causes of 4.8 (1.6–14) and 2.1 (0.8–5.8). MoXLP bearings were associated with better survival than MoM and CoC bearings, mainly because of lower risk of revision due to aseptic loosening and ‘other’ causes

Satisfactory intermediate and long-term results of rotational acetabular osteotomy (RAO) for the treatment of early osteoarthritis secondary to developmental dysplasia of the hip have been reported. The purpose of this study is to examine the 30-year results of RAO. Between 1987 and 1994, we treated 49 patients (55 hips) with RAO for diagnosis of pre- OA or early-stage OA. Of those patients, 35 patients (43 hips) were available at a minimum of 28 years. The follow-up rate was 78.2% and the mean follow-up was 30.5 years. The mean age at the time of surgery was 34 years. Clinical evaluation was performed with the Merle d'Aubigne and Postel rating scale, and radiographic analyses included measurements of the center-edge angle, acetabular roof angle, and head lateralization index on preoperative, postoperative AP radiographs of the pelvis. Postoperative joint congruency was classified into four grades. The radiographic evidence of progression of OA was defined as the minimum joint space less than 2.5mm. The mean preoperative clinical score was 14.0, which improved to a mean of 15.3 at the time of the latest follow-up. The mean center-edge angle improved from 0.6° preoperatively to 34° postoperatively, the mean acetabular roof angle improved from 28.4°preoperatively to 1.0°postoperatively, the mean head lateralization index improved from 0.642 preoperatively to 0.59 postoperatively. Postoperative joint congruency was excellent in 11 hips, good in 29 hips, and fair in 3 hips. Nineteen patients (20 hips) had radiographic OA progression, and 10 patients (11 hips) were converted to THA. Kaplan-Meier survivorship analysis, with radiographic OA progression as the end point, predicted survival of 75.6% at 20 years and 48.8% at 30 years, and with THA conversion as the end point, 90.2% at 20 years and 71.2% at 30 years. The RAO is an effective surgical procedure for symptomatic dysplastic hips of pre- and early-stage OA and could change the natural history of the dysplastic hip

Total hip arthroplasty (THA) is one of the most successful and commonly performed surgical interventions worldwide. Based on registry data, at one-year post THA, implant survivorship is nearly 100% and patient satisfaction is 90%. A novel, porous coated acetabular implant was introduced in Europe and Australia in 2007. Several years after its introduction, warnings were issued for the system when used with metal-on-metal bearings due to adverse local tissue reaction, with one study reporting a 24% failure rate (Dramis et al. 2014). A subsequent 2018 study by Teoh et al. showed that the acetabular system had a survival rate of 98.9% at five years when used with conventional polyethylene or ceramic bearing surfaces. The current study was conducted to determine the safety and effectiveness of the acetabular system using standard highly-crosslinked polyethylene (XLPE) and ceramic liners at five-year follow-up. Our hypothesis was that the acetabular system would exhibit survivorship comparable to other acetabular components on the market at five-year follow-up. A prospective, non-randomized study was conducted from February 2009 to June 2017 at eight sites in Canada and the USA. One hundred fifty-five hips were enrolled and 148 hips analyzed after THA indicated for degenerative arthritis. At five-year follow-up, 103 subjects remained for final analysis. All patients received a zero, three, or multi-hole R3 acetabular shell with Stiktite porous coating (Smith & Nephew, Inc., Memphis, TN, USA). Standard THA surgical techniques were employed, with surgical approach and either of a XLPE or ceramic bearing surface chosen at the discretion of the surgeon. The primary outcome was revision at five-years post-op with secondary outcomes including the Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), radiographic analysis, and post-operative adverse events. Data and outcomes were analyzed using summary statistics with 95% confidence intervals, t-tests, and Wilcoxon Rank tests. At five-year follow-up the overall success rate was 97.14% (95% CI: 91.88–100). When analyzed by liner type, the success rate was 96.81% (95% CI: 90.96–99.34) for polyethylene (n=94) and 100% (95% CI: 71.51–100) for ceramic (n=11), with no significant difference between either liner type (p=1). There were three revisions during the study (1.9%), two for femoral stem revision post fracture, and one for deep infection. The HHS (51.36 pre-op, 94.50 five-year), all 5 HOOS sub-scales, and WOMAC (40.9 pre-op, 89.13 five-year) scores all significantly improved (p < 0 .001) over baseline scores at all follow-up points. One (0.7%) subject met the criteria for radiographic failure at one-year post-op but did not require revision. Six (1.8%) of the reported adverse events were considered related to the study device, including four cases of squeaking, one bursitis, and one femur fracture. Results from this five-year, multicenter, prospective study indicate good survivorship for this novel, porous coated acetabular system. The overall survivorship of 97.14% at five-year follow-up is comparable to that reported for similar acetabular components and aligns with previous analyses (Teoh et al. 2018)

Background: Structural hip deformities including developmental dysplasia of the hip (DDH) and femoroacetabular impingement (FAI) are thought to predispose patients to degenerative joint changes. However, the natural history of these malformations is not clearly delineated. Methods: Seven-hundred twenty-two patients ≤55 years that received unilateral primary total hip arthroplasty (THA) from 1980–1989 were identified. Pre-operative radiographs were reviewed on the contralateral hip and only hips with Tönnis Grade 0 degenerative change that had minimum 10-year radiographic follow-up were included. Radiographic metrics in conjunction with the review of two experienced arthroplasty surgeons determined structural hip diagnosis as DDH, FAI, or normal morphology. Every available follow-up AP radiograph was reviewed to determine progression from Tönnis Grade 0–3 until the time of last follow-up or operative intervention with THA. Survivorship was analyzed by Kaplan-Meier methodology, hazard ratios, and multi-state modeling. Results: One-hundred sixty-two patients met all eligibility criteria with the following structural diagnoses: 48 DDH, 74 FAI, and 40 normal. Mean age at the time of study inclusion was 47 years (range 18–55), with 56% females. Mean follow-up was 20 years (range 10 – 35 years). Thirty-five patients eventually required THA: 16 (33.3%) DDH, 13 (17.6%) FAI, 6 (15.0%) normal. Kaplan-Meier analysis demonstrated that patients with DDH progressed most rapidly, followed by FAI, with normal hips progressing the slowest. The mean number of years spent in each Tönnis stage by structural morphology was as follows: Tönnis 0: DDH = 17.0 years, FAI = 14.8 years, normal = 22.9 years; Tönnis 1: DDH = 12.2 years, FAI = 13.3 years, normal = 17.5 years; Tönnis 2: DDH = 6.0 years, FAI = 9.7 years, normal = 8.6 years; Tönnis 3: DDH = 1.6 years, FAI = 2.6 years, normal = 0.2 years. Analysis of degenerative risk for categorical variables showed that patients with femoral head lateralization >10 mm, femoral head extrusion indices >0.25, acetabular depth-to-width index <0.38, lateral center-edge angle <25 degrees, and Tönnis angle >10 degrees all had a greater risk of progression from Tönnis 0 to Tönnis 3 or THA. Among patients with FAI morphology, femoral head extrusion indices >0.25, lateral center-edge angle <25 degrees, and Tönnis angle >10 degrees all increased the risk of early radiographic progression. Analysis of degenerative risk for continuous variables using smoothing splines showed that risk was increased for the following: femoral head lateralization >8 mm, femoral head extrusion index >0.20, acetabular depth-to-width index <0.30, lateral center-edge angle <25 degrees, and Tönnis angle >8 degrees. Conclusions: This study defines the long-term natural history of DDH and FAI in comparison to structurally normal young hips with a presumably similar initial prognostic risk (Tönnis Grade 0 degenerative change and contralateral primary THA). In general, the fastest rates of degenerative change were observed in patients with DDH. Furthermore, risk of progression based on morphology and current Tönnis stage were defined, creating a new prognostic guide for surgeons. Lastly, radiographic parameters were identified that predicted more rapid degenerative change, both in continuous and categorical fashions, subclassified by hip morphology

Aims

The aim of this study was to assess the clinical and radiological outcomes of an antiprotrusio acetabular cage (APC) when used in the surgical treatment of periacetabular bone metastases.

Purpose: The purpose of this study was to determine the greater than 20 year survivorship of the PCA total hip arthroplasty (THA) in patients with severe hip osteoarthritis. Method: A prospective follow-up of 315 consecutive patients treated with a PCA cementless THA in patients with hip osteoarthritis was performed. Patients had postoperative assessments and radiographs every two years. Overall THA, femoral stem and acetabular cup revisions and Kaplan-Meier survivorship was determined. Revision rates and survivorship was also investigated across gender. Results: The mean age of our patients was 61 years old (range 20 to 86) with 47% female patients. 226 cases used a 26mm articulation and 89 cases a 32mm articulation. At 23 years follow-up, 188(60%) patients were alive with retained implants while 85(27%) were deceased with still implants that were functioning well. Forty-two cases (13%) were revised (30 sockets, 13 stems), five of which later deceased. The 20 year Kaplan Meier survivorship for the overall THA, stem component and acetabular cup were 86%, 97% and 90% respectively. Survivorship of the acetabular cup for 26mm and 32mm articulations was 92% and 85% respectively (p=0.016). Females had a worse THA survivorship than males, 82% and 91% respectively (p=0.036). Conclusion: The PCA cementless THA has performed well beyond 20 years with 26 mm articulations doing better than 32 mm, and male gender associated with better outcomes. The authors postulate that polyethylene thickness is key to predicting failure

Many factors can negatively impact acetabular component positioning including poor visualization, increased patient size, inaccuracies of mechanical guides, and inconsistent precision of conventional instruments and techniques, and changes in patient positioning. Improper orientation contributes to increased dislocation rates, leg length discrepancies, altered hip biomechanics, component impingement, acetabular component migration, bearing surface wear, and pelvic osteolysis thus affecting revision rates and long-term survivorship. Despite the established definitions of acetabular safe zones, recent analysis of U.S. Medicare THA data found dislocation rates during the first six months to be 3.9% for primary surgeries and 14.4% for revision surgeries. Accurate and precise acetabular component orientation during initial THA is an increasingly important factor in decreasing revision THA; a recent report cites instability and dislocation as the primary cause of revision accounting for 22.5% of cases. Larger femoral heads and alternative bearing couples are less tolerant of variation in acetabular orientation and thus are poor substitutes for proper acetabular component placement. Variability in acetabular orientation has been reported to have both an inter-surgeon and an intra-surgeon component; pre-surgical templating combined with intraop-erative measurements is subject to inconsistencies and errors. Current methods for determining acetabular orientation include preoperative imaging such as CT scans, intraoperative imaging such as plain radiographs and fluoroscopy, and intraoperative anatomical tests. Combining the concepts of patient-specific morphology (PSM) and quantitative technologies (QuanTech) such as computer-assisted navigation (CAN) has the potential to maximise range of motion and to further improve acetabular component orientation through improved accuracy and precision. PSM refers to the practice of allowing the form and structure of the patient’s hip joint to guide surgical reconstruction and component placement thus creating an individualised and more accurate “target zone”; unlike “safe zones,” PSM does not rely on averages. Although gross anatomic changes may make it difficult to use PSM, certain structures may be used as guide-posts for orientation, alignment, and stability in most patients. At present, there are three options when considering anatomic landmarks as guides for acetabular component placement: bony landmarks, soft tissue landmarks, or a combination. QuanTech has been shown to increase the precision of component placement by reducing intra-surgeon deviation. Some pitfalls of current CAN techniques result from maintaining camera line of sight during surgery, registration process, and pin placement. Performing THA using smaller incisions can impose additional complications as well as risks for errors in component positioning; QuanTech has the potential to provide greater visualization and precision, thus decreasing the impact of those constraints. THA has become one of the most common and successful orthopaedic procedures; its efficacy at relieving pain and its ability to help patients have improved quality of life is without dispute yet results continue to vary with inter-surgeon and intra-surgeon differences. As the population needing THA increases, the prevalence of complications and problems will increase, even if the percentage of complications decreases. Coupling PSM with QuanTech such as CAN may allow the surgeon to decrease variability and more consistently implant THA components based on each patient’s individualized requirements. The goal of combining PSM and CAN is to further reduce inter-and intra-surgeon variation, thereby decreasing outliers, complications, and revision rates, and possibly narrowing the gap between specialist and generalist. More accurate and precise acetabular component orientation correlates with better hip biomechanics, translating into better function, fewer dislocations, fewer impingements, maximized safe range of motion, less wear, and therefore less aseptic loosening and improvements in survivorship of primary THA. Decreasing revision rates, combined with the benefits listed above, could translate into increased THA survivorship, improved patient satisfaction, and decreased economic burden on the entire healthcare system

Aims

The prevalence of ipsilateral total hip arthroplasty (THA) and total knee arthroplasty (TKA) is rising in concert with life expectancy, putting more patients at risk for interprosthetic femur fractures (IPFFs). Our study aimed to assess treatment methodologies, implant survivorship, and IPFF clinical outcomes.

Aims

Joint registries typically use revision of an implant as an endpoint and report survival rates after a defined number of years. However, reporting lifetime risk of revision may be more meaningful, especially in younger patients. We aimed to assess lifetime risk of revision for patients in defined age groups at the time of primary surgery.